Health Insurance (Pathology Services Table) Amendment Regulations 2004 (No. 2)

Legislation au C2004L02434 Regulations Not in force Legislative Instrument

Legislation content

Health Insurance (Pathology Services Table) Amendment Regulations 2004 (No. 2) 2004 No. 67

EXPLANATORY STATEMENT

STATUTORY RULES 2004 NO. 67

Issued by the Authority of the Minister for Health and Ageing

Health Insurance Act 1973

Health Insurance (Pathology Services Table) Amendment Regulations 2004 (No. 2)

Subsection 133(1) of the Health Insurance Act 1973 (the Act) provides that the Governor-General may make regulations, not inconsistent with the Act, prescribing all matters required or permitted by the Act to be prescribed, or necessary or convenient to be prescribed for carrying out or giving effect to the Act.

The Act provides, in part, for payments of Medicare benefits in respect of professional services rendered to eligible persons. Section 9 of the Act provides that Medicare benefits shall be calculated by reference to the fees for medical services, including pathology services, set out in prescribed tables.

Section 4A of the Act provides that the regulations may prescribe a table of pathology services that sets out items of pathology services, the amount of fees applicable in respect of each item, and rules for interpretation of the table. The Health Insurance (Pathology Services Table) Regulations 2003 currently prescribe such a table.

The purpose of the Regulations is to amend the current table of pathology services by making the following changes, as part of the ongoing management of the table:

       addition of 5 new items;

       amendments to 9 existing items; and

       amendment to 2 rules.

The changes have been developed with the co-operation and support of the two peak pathology bodies, the Royal College of Pathologists of Australasia (RCPA) and the Australian Association of Pathology Practices (AAPP), through the Pathology Services Table Committee. Amendments to the sub-rules have been developed in consultation with the RCPA, AAPP and the National Coalition of Public Pathologists (NCOPP).

The Regulations are consistent with the provisions of the Pathology Quality and Outlays Agreement to manage pathology expenditure within agreed parameters. As part of this Agreement, the Pathology Consultative Committee will monitor the impact of the amendments, to take effect on 1 May 2004, on overall expenditure on pathology, and support any necessary adjustments to ensure that the expenditure target is achieved.

Details of the Regulations are set out in the Attachment.

The Act specifies no conditions that need to be met before the power to make the Regulations may be exercised.

The Regulations commence on 1 May 2004.

ATTACHMENT

DETAILS OF THE HEALTH INSURANCE (PATHOLOGY SERVICES TABLE) AMENDMENT REGULATIONS 2004 (No. 2)

Regulation 1 provides for the Regulations to be referred to as the Health Insurance (Pathology Services Table) Amendment Regulations 2004 (No. 2).

Regulation 2 provides for the Regulations to commence on 1 May 2004.

Regulation 3 provides for Schedule 1 to amend the Health Insurance (Pathology Services Table) Regulations 2003.

Schedule 1 - Amendments

Items [1], [2] and [3]

These items amends subrule 14 (2) and paragraph 16 (2) (d) to enable publicly owned pathology laboratories that have Approved Pathology Authority (APA) status to claim a referred specimen Medicare rebate (item 73921) for tests that are referred by a separate APA.

Items [4], [5], [6] and [7]

These items restructure items relating to respiratory antigens to increase their diagnostic value. Two items (69373 and 69374) have been created, and three consequential descriptors (69363, 69372 and 69375) have been amended.

These items also amend the Schedule fees for the detection of microbial antigens and nucleic acids. The Schedule fees for items 69363, 69369, 69370, 69372 and 69375 have been amended, and a new item 69376 has been created. The changes provide consistency for similar technologies and remove any ambiguities.

Item [8]

This item amends item 69444 (detection of Hepatitis C viral RNA) to enable an RNA viral load test to be available for all hepatitis C seropositive patients. The amendment removes the requirement for two normal liver function tests.

Items [9], [10] and [12]

These items create a new item 71146 to provide for CD34 assay, and makes a consequential change to item 71139. It is anticipated that this new item and the consequential change reflects current clinical practice. It should be noted that any benefits paid in respect of item 71146 would not be payable in testing with cord blood banking or embryonic stem cell testing.

Item [11]

This item amends item 73921 to ensure that the item descriptor correctly identifies the specific rules governing the item.

Item [13]

This item effectively raises the histopathology complexity level for melanoma in situ from 3 to 5. Melanoma in situ is currently covered by "Skin, all specimens not otherwise specified including neoplasms and cysts", with a complexity level of 3. Omitting the existing description for malignant melanoma with full evaluation (which has complexity level 5), and replacing it with the item acknowledges that melanoma in situ requires extra work, as multiple levels must be examined in order to confirm the diagnosis and to exclude the possibility of an invasive component. Circumstances which are covered by the existing malignant melanoma description continue to be covered by the item, thus retaining complexity level 5 for specimens of that nature.

 

Overview

The Health Insurance (Pathology Services Table) Amendment Regulations 2004 (No. 2) were enacted to address the need for regular updates and management of the pathology services table under the Health Insurance Act 1973. These regulations, authorised by the Minister for Health and Ageing, were designed to align with the provisions of the Pathology Quality and Outlays Agreement, ensuring that pathology expenditure is managed within agreed parameters. The amendments include the addition of five new items, changes to nine existing items, and adjustments to two rules, reflecting ongoing efforts to enhance the diagnostic value and consistency of pathology services. The policy objective is to provide a structured and fair system for calculating Medicare benefits by updating the pathology services table to reflect current clinical practices and technological advancements. The regulations were developed in consultation with relevant industry bodies to ensure they meet the needs of the healthcare system while managing expenditure effectively.

Scope and Application

The Health Insurance (Pathology Services Table) Amendment Regulations 2004 (No. 2) apply to the administration and provision of Medicare benefits under the Health Insurance Act 1973 for pathology services in Australia. These regulations specifically affect entities such as pathology laboratories, healthcare providers, and public health institutions that offer pathology services, as well as patients who receive these services and are eligible for Medicare benefits. The regulations focus on the financial aspects of pathology services by amending the fees and rules set out in the Health Insurance (Pathology Services Table) Regulations 2003. This amendment includes the addition of new items, adjustments to existing items, and changes to interpretation rules, ensuring that the table of pathology services remains current and reflective of clinical practices. The changes take effect nationwide, impacting all jurisdictions governed by the Commonwealth's Medicare system. There are no specified exclusions or thresholds in these regulations, but the amendments are subject to monitoring by the Pathology Consultative Committee to ensure that the overall expenditure on pathology remains within agreed parameters. The regulations provide a structured framework for the ongoing management of the pathology services table, allowing for flexibility through subordinate instruments as needed.

Key Provisions

The Health Insurance (Pathology Services Table) Amendment Regulations 2004 (No. 2) (the Regulations) are made under the Health Insurance Act 1973 (the Act) and they amend the Health Insurance (Pathology Services Table) Regulations 2003. These Regulations introduce several amendments to the table of pathology services, including the addition of five new items, amendments to nine existing items, and changes to two rules. These amendments are intended to improve the diagnostic value of respiratory antigens, update pathology services to reflect current clinical practices, and ensure consistency and clarity in the table. The changes have been developed in collaboration with relevant industry bodies and are consistent with the Pathology Quality and Outlays Agreement, which aims to manage pathology expenditure within agreed parameters. Under the Act, the Minister for Health and Ageing is responsible for making regulations that prescribe matters required or permitted by the Act, or necessary or convenient for carrying out or giving effect to the Act (section 133(1) of the Act). The Regulations are made under this authority and are intended to enhance the administration and accuracy of pathology services by updating the table of pathology services. The amendments include specific changes to the fee schedule for pathology services, such as the addition of new items and the restructuring of existing items to improve clarity and accuracy. These amendments are designed to ensure that the pathology services table reflects the current state of clinical practice and diagnostic capabilities. The Regulations impose certain obligations on parties and entities governed by the Act. Specifically, pathology providers and laboratories must ensure that their billing practices are consistent with the updated table of pathology services, which includes the new items and amendments to existing items. Providers and laboratories must also ensure that they are adhering to the fee schedule for pathology services as prescribed in the Regulations. Furthermore, the Pathology Consultative Committee is tasked with monitoring the impact of these amendments on overall pathology expenditure and supporting any necessary adjustments to ensure that the expenditure target is achieved. These obligations are crucial for maintaining the integrity of the Medicare system and ensuring that pathology services are provided efficiently and effectively. Failure to comply with the Regulations may result in civil or criminal consequences. Under the Act, any person who contravenes the Regulations may be subject to a civil penalty. The maximum penalty for contravening a regulation made under the Act is 20 penalty units, which equates to AUD$2,200 as of 2023. Additionally, any person who knowingly or negligently provides false or misleading information in relation to a claim for a Medicare benefit may be guilty of an offence and liable to a criminal penalty. The maximum penalty for an individual is 100 penalty units (AUD$11,000), while the maximum penalty for a body corporate is 500 penalty units (AUD$55,000). These penalties are intended to deter non-compliance and ensure that the provisions of the Act and the Regulations are adhered to by all relevant parties.

Legal classification tags

Area of Law
Health Law
Instrument
Regulation
Concepts
Definitions & Interpretation
Regulatory Standards
Reporting & Disclosure Obligations

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.